1. Home
  2. VHC vs RNXT Comparison

VHC vs RNXT Comparison

Compare VHC & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VirnetX Holding Corp

VHC

VirnetX Holding Corp

N/A

Current Price

$13.26

Market Cap

46.0M

Sector

Miscellaneous

ML Signal

N/A

Logo RenovoRx Inc.

RNXT

RenovoRx Inc.

N/A

Current Price

$1.29

Market Cap

42.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VHC
RNXT
Founded
2005
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
46.0M
42.4M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
VHC
RNXT
Price
$13.26
$1.29
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.25
AVG Volume (30 Days)
13.6K
458.9K
Earning Date
05-13-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
0.99
20.00
EPS
N/A
N/A
Revenue
$162,000.00
$1,123,000.00
Revenue This Year
N/A
$194.66
Revenue Next Year
N/A
$279.78
P/E Ratio
N/A
N/A
Revenue Growth
3140.00
2511.63
52 Week Low
$9.82
$0.70
52 Week High
$29.00
$1.51

Technical Indicators

Market Signals
Indicator
VHC
RNXT
Relative Strength Index (RSI) N/A 62.45
Support Level N/A $0.82
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.12
MACD 0.00 0.02
Stochastic Oscillator 0.00 59.92

Price Performance

Historical Comparison
VHC
RNXT

About VHC VirnetX Holding Corp

VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. Its software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services and critical infrastructures.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: